PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: abanerji@mgh.harvard.edu.\', \'Harvard Medical School, Boston, Mass; Division of Allergy and Immunology, Department of Medicine, Brigham and Women\'s Hospital, Boston, Mass.\', \'Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.\', \'Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.\', \'Allergy Division, University of Washington School of Medicine, Seattle, Wash.\', \'Division of Allergy & Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.\', \'Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Edward P. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Boston, Mass.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2213-2198(20)31411-210.1016/j.jaip.2020.12.047
?:hasPublicationType
?:journal
  • The journal of allergy and clinical immunology. In practice
is ?:pmid of
?:pmid
?:pmid
  • 33388478
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all